Gen Suzuki
Papers
2
Total Citations
58
H-Index
2
About
Gen Suzuki is a leading radiation oncologist whose research focuses on reirradiation strategies for recurrent head and neck cancers, with a particular emphasis on advanced stereotactic techniques. Dr. Suzuki’s major contributions lie in evaluating the efficacy and toxicity of salvage treatments for patients who have exhausted standard radiotherapy options. In a pivotal 2016 study (47 citations), they conducted a retrospective multi-institutional review of 107 patients undergoing CyberKnife-based stereotactic body reirradiation, providing critical insights into prognosis and the specific risk of mucosal ulceration. Further expanding this work, Dr. Suzuki led a multi-institutional matched-cohort analysis comparing outcomes of charged particle radiotherapy versus CyberKnife stereotactic radiotherapy for recurrent head and neck cancers (11 citations). This comparative effectiveness research helps guide clinical decision-making for this challenging patient population. By systematically analyzing survival outcomes and toxicities across different reirradiation modalities, Dr. Suzuki has advanced the evidence base for personalized salvage therapy, directly impacting treatment protocols for patients with limited options. Their work continues to shape the field of radiation oncology by defining safer, more effective reirradiation approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2